DexCom (DXCM) Misses Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
DexCom (DXCM) PT Lowered to $105 at Oppenheimer; 'Buying on Weakness'
July 29, 2022 7:25 AM EDTOppenheimer analyst Steven Lichtman lowered the price target on DexCom (NASDAQ: DXCM) to $105.00 (from $525.00) while maintaining an Outperform rating following weak results. The analyst is buying on weakness.
The analyst commented, "DexCom's 2Q22 sales of $696.2M (+17% y/y) slightly lagged our/Street's... More
